[1]
“A Cross-Sectional Study on Evaluation of Ige Levels in Subjects with Atopic Dermatitis”, Journal of Pharmaceutical Negative Results, vol. 13, pp. 2145–2148, Nov. 2022, doi: 10.47750/pnr.2022.13.S05.337.